Drug search by name

Revonto and Cardiac disease

Result of checking the interaction of drug Revonto and disease Cardiac disease for safety when used together.

Check result:

Revonto <> Cardiac disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Pericarditis, both with and without pleural effusion, has occasionally occurred during the long-term administration of dantrolene. It has not been reported with intravenous use in the emergency treatment of malignant hyperthermia crises. Other adverse cardiovascular effects include tachycardia, erratic blood pressure, and heart failure. Prolonged therapy with dantrolene should be administered cautiously in patients with significantly impaired cardiac function, especially if due to myocardial disease.

References:

"Product Information. Dantrium (dantrolene)." Procter and Gamble Pharmaceutic, Cincinnati, OH.
Petusevsky ML, Faling LJ, Rocklin RE, Snider GL, Merliss AD, Moses JM, Dorman SA "Pleuropericardial reaction to treatment with dantrolene." JAMA 242 (1979): 2772-4

Revonto

Generic Name: dantrolene

Brand Name: Dantrium, Revonto, Dantrium Intravenous, Ryanodex

Synonyms: Revonto Injection

What is Revonto?